These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 3986938
21. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa]. Cluzel M, Chanal M, Sirot J, Cluzel R. Nouv Presse Med; 1982 Nov 18; 11(46):3400-4. PubMed ID: 6818523 [Abstract] [Full Text] [Related]
22. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin. Møller NE, Eriksen KR, Feddersen C, Flensborg EW, Høiby N, Norn S, Rosendal K, Schiøtz PO, Skov PS. Eur J Respir Dis; 1982 Mar 18; 63(2):130-9. PubMed ID: 6461561 [Abstract] [Full Text] [Related]
23. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species. Rahal JJ. Clin Infect Dis; 2006 Sep 01; 43 Suppl 2():S95-9. PubMed ID: 16894522 [Abstract] [Full Text] [Related]
24. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins. Smith BR. Clin Pharm; 1984 Sep 01; 3(4):373-85. PubMed ID: 6380902 [Abstract] [Full Text] [Related]
25. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Georges B, Conil JM, Dubouix A, Archambaud M, Bonnet E, Saivin S, Lauwers-Cancès V, Cristini C, Cougot P, Decun JF, Mathe O, Chabanon G, Marty N, Seguin T, Houin G. Crit Care Med; 2006 Jun 01; 34(6):1636-41. PubMed ID: 16557152 [Abstract] [Full Text] [Related]
30. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Fish DN, Piscitelli SC, Danziger LH. Pharmacotherapy; 1995 Jun 01; 15(3):279-91. PubMed ID: 7667163 [Abstract] [Full Text] [Related]
31. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Hayes D, Kanga JF, Anstead MI, Kuhn RJ. Pediatr Pulmonol; 2008 May 01; 43(5):511-3. PubMed ID: 18383117 [Abstract] [Full Text] [Related]
32. [Antibiotic treatment of cystic fibrosis]. de Montalembert M, Berche P, Lenoir G. Ann Pediatr (Paris); 1991 Oct 01; 38(8):523-8. PubMed ID: 1746849 [Abstract] [Full Text] [Related]
33. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D, Stableforth D. Drugs; 2000 Nov 01; 60(5):1053-64. PubMed ID: 11129122 [Abstract] [Full Text] [Related]
34. [Treatment of severe infections: should one always administer an aminoglycoside?]. Cometta A, Baumgartner JD. Schweiz Med Wochenschr Suppl; 1996 Nov 01; 76():28S-33S. PubMed ID: 8677416 [Abstract] [Full Text] [Related]
35. Correlation between activity of beta-lactam agents in vitro and bacteriological outcome in acute pulmonary exacerbations of cystic fibrosis. Gaillard JL, Cahen P, Delacourt C, Silly C, Le Bourgeois M, Coustère C, de Blic J, Lenoir G, Scheinmann P. Eur J Clin Microbiol Infect Dis; 1995 Apr 01; 14(4):291-6. PubMed ID: 7649191 [Abstract] [Full Text] [Related]
37. Azlocillin in cystic fibrosis. Malmborg AS, Alfredsson H, Strandvik B. Isr J Med Sci; 1983 Nov 01; 19(11):1001-3. PubMed ID: 6662681 [Abstract] [Full Text] [Related]
38. Value of inhaled antibiotics in cystic fibrosis patients. Wunderlich P, Paul KD, Wehner J. Acta Univ Carol Med (Praha); 1990 Nov 01; 36(1-4):34-6. PubMed ID: 2130713 [Abstract] [Full Text] [Related]
40. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases]. Avril JL, Cayla AM, Guist'hau O, Moillo-Batt A. Pathol Biol (Paris); 1983 Jun 01; 31(6):471-5. PubMed ID: 6410345 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]